Mighty Therapeutics
Chemicals & Related Products · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
123 Highland Ave # 201, Needham, Massach...Phone Number
(617) 600-6888Website
www.mightytx.comRevenue
$33.9 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Mighty Therapeutics
Mighty Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies that target mitochondrial dysfunction in rare genetic, ophthalmic, and neurodegenerative diseases. The company advances novel treatments through research, clinical development, and patient collaboration to improve outcomes for individuals with high unmet medical needs. Its portfolio includes the first approved therapy for Barth syndrome and investigational programs for additional mitochondrial disorders.Explore more
Popular SearchesMighty TherapeuticsSIC Code 28,283NAICS Code 32,325Show moreMighty Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mighty Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Mighty Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Mighty Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mighty Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Mighty Therapeutics
Click to see if Mighty Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Mighty Therapeutics has new funding data
Earning: See what the market has to say on Mighty Therapeutics recently announced quarterly report
Product Launch: Get notified when Mighty Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Mighty Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mighty Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mighty Therapeutics.
Mighty Therapeutics News & Media
Mighty Therapeutics Secures Up to $150 Million to Progress Commercial and Clinical Development of New Class of Mitochondrial Targeted Medicines
- Investment secures runway to reach cash flow positivity - NEEDHAM, Mass., July 14, 2026 /PRNewswire/ -- Mighty Therapeutics Holdings Inc. (the "Company" or "Mighty"), a commercial-stage biotechnology company pioneering a new class of medicines that directly target mitochondrial...Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome
– Comprehensive updates to be presented at Barth Syndrome Foundation conference – NEEDHAM, Mass., July 8, 2026 /PRNewswire/ -- Mighty Therapeutics (the "Company" or "Mighty"), a commercial-stage biotechnology company pioneering a new class of medicines that directly target mitochondrial...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mighty Therapeutics
Sign Up For FreeTo access detailed company insights
Mighty Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies that target mitochondrial dysfunction in rare genetic, ophthalmic, and neurodegenerative diseases. The company advances novel treatments through research, clinical development, and patient collaboration to improve outcomes for individuals wi... Read More
